Footnotes
ID | footnote |
f1 |
the reported sales were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on april 10, 2020. the sale of these shares was intended primarily to offset the reporting person's anticipated tax liability and exercise price in connection with the exercise of stock options set to expire on july 15, 2020. |
f2 |
this sale price represents the weighted average sale price of the shares sold ranging from $20.71 to $21.67 per share. upon request by the commission staff, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this form 4. |
f3 |
the sale of these shares were intended primarily to offset the reporting person's anticipated tax liability and exercise price in connection with the exercise of stock options set to expire on july 15, 2020. |
f4 |
this sale price represents the weighted average sale price of the shares sold ranging from $20.52 to $20.635 per share. upon request by the commission staff, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this form 4. |
f5 |
the shares subject to the option are fully vested and exercisable. |